Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by wildbird1on Nov 18, 2023 11:54am
386 Views
Post# 35742600

50 millions sharks shares...

50 millions sharks shares...Contrary to some, I am pleased with this new offering.

Let's see the facts.
1) A non-brokered private placement, give priority to "management & insiders plus accredited investors" on the offering.
2) The RCC(Research Capital Corporation) offering would have added approximately 50 millions shares to the total shares count.
3) This new offering will add approximately 12 millions shares to the total shares count.

My take on this offering is, it doesn't matter why the RCC offering was terminated( in the PressRelease no reasons given), a much smaller offering of just 12 millions shares in the hands of TLT insiders is much better than 50 millions sharks shares.

In short...
12 millions shares in the hands of TLT insiders versus 50 millions sharks shares in the hands of suspicious investors... This new offering is a plus for all TLT small & big investors.


<< Previous
Bullboard Posts
Next >>